A project from the American Society of Retina SpecialistsSign in to view content
Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications
- Video
- Published 2023
Related
Category: Retinal Detachment